These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12394229)

  • 1. The effect of mannitol infusion on the response to diuretic therapy in cirrhotic patients with ascites.
    Pamuk ON; Sonsuz A
    J Clin Gastroenterol; 2002; 35(5):403-5. PubMed ID: 12394229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravenous mannitol in mobilization of resistant cirrhotic ascites.
    Raza MA; Qureshi UF; Humayoun MA; Waseem T; Akram J
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):184-8. PubMed ID: 21183857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Ljubicić N; Kujundzić M; Banić M; Vrkljan M
    Scand J Gastroenterol; 1998 Apr; 33(4):441-7. PubMed ID: 9605268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites.
    Yang YY; Lin HC; Lin MW; Chu CJ; Lee FY; Hou MC; Lee SD; Lee WP; Liu TT; Jap TS
    Clin Sci (Lond); 2011 Dec; 121(11):509-21. PubMed ID: 21692745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
    Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
    Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
    Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reasons for diuretic therapy of cirrhotic ascites].
    Parlapiano C; Paoletti V
    Minerva Med; 1985 Nov; 76(43):2043-6. PubMed ID: 3934593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic usefulness of the random urine Na/K ratio in predicting therapeutic response for diuretics in cirrhotic patients with ascites.
    Mohii el SM; El Mansy IM; Salah M; Khedr MA
    J Egypt Soc Parasitol; 2013 Dec; 43(3):767-76. PubMed ID: 24640876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].
    Brunkhorst R; Wrenger E; Kühn K; Schmidt FW; Koch K
    Klin Wochenschr; 1989 Aug; 67(15):774-83. PubMed ID: 2671477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
    Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium sparing diuretics as adjunct to mannitol therapy in neurocritical care patients with cerebral edema: effects on potassium homeostasis and cardiac arrhythmias.
    Bilotta F; Giovannini F; Aghilone F; Stazi E; Titi L; Zeppa IO; Rosa G
    Neurocrit Care; 2012 Apr; 16(2):280-5. PubMed ID: 22101724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepped care medical treatment for cirrhotic ascites: analysis of factors influencing the response to treatment.
    Takaya A; Fukui H; Matsumura M; Uemura M; Kojima H; Okamoto S; Tsujii T
    J Gastroenterol Hepatol; 1995; 10(1):30-5. PubMed ID: 7620104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial.
    Tang J; Wang Y; Han T; Mao Q; Cheng J; Ding H; Shang J; Zhang Q; Niu J; Ji F; Chen C; Jia J; Jiang X; Lv N; Gao Y; Wang Z; Wei Z; Chen Y; Zeng M; Mao Y
    BMC Gastroenterol; 2020 Nov; 20(1):391. PubMed ID: 33213378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased urinary volumes in symptomatic Ménière's Disease.
    Di Berardino F; Zanetti D
    BMC Res Notes; 2019 Dec; 12(1):826. PubMed ID: 31878980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
    Knauf H; Mutschler E
    Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of non-sodium restricted diet with diuretics on plasma rennin, renal blood flow and in patients with cirrhotic ascites].
    Zhu YF; Gu XB; Zhu HY; Yang XJ; Wang D; Yu P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):50-3. PubMed ID: 23855131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.